Browsing Biologie des maladies cardiovasculaires (BMC) - UMR 1034 by Author "UGO, Valérie"
Now showing items 1-6 of 6
-
Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression
COTTIN, Laurane; RIOU, Jérémie; ORVAIN, Corentin ...(British Journal of Haematology. vol. 188, n° 6, pp. 935–944, 2020)Article de revue -
Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) study
MANSIER, Olivier; LUQUE PAZ, Damien; IANOTTO, Jean-Christophe ...(American Journal of Hematology. vol. 93, n° 4, pp. E84–E86, 2018-08)Article de revueRestricted access -
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.
LUQUE PAZ, Damien; RIOU, Jeremie; VERGER, Emmanuelle ...(Blood Advances. vol. 5, n° 5, pp. 1442-1451, 2021-03-09)Article de revue -
JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.
SUREAU, Léa; BUORS, Caroline; IANOTTO, Jean-Christophe ...(Blood Cancer Journal. vol. 12, n° 4, pp. 56, 2022-04-08)Article de revueOpen access -
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
AUBIN, Laura; VILAS BOAS, Rúben; DALTRO DE OLIVEIRA, Rafael ...(American Journal of Hematology, 2024-02-25)Article de revueOpen access